Donald Kimpel is a Rheumatology/Immunology physician affiliated with University of Virginia. OpenAlex indexes 54 publications with 1,234 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
415 Ray C. Hunt Dr
Ste 2100
Charlottesville, VA 22903
Telephone
434-243-0223Provider last certified this registry record 10 Aug 2023.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202511 payments
- Amgen Inc.Program year20241 payment
- Amgen Inc.Program year202313 payments$10,255openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
35%Folate Analog Metabolic Inhibitor21.1%Methotrexate100%Part D≥37 patientsAntirheumatic Agent5%Leflunomide100%Part D<11 patients+ 3 more classes in this area
Antiparasitic
26.7%Antimalarial26.7%Hydroxychloroquine Sulfate100%Part D≥38 patientsNervous system
19%Opioid Agonist9.9%Tramadol Hcl65%Oxycodone Hcl35%Part D<11 patientsGabapentinoids3.7%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2003–2003 per NIH RePORTER. The latest:
- NOVEL IMAGING TECHNOLOGIES FOR RHEUMATOID ARTHRITIS
University of Virginia Charlottesville
FY2003$304,000R01AR046976
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis
Frontiers in Immunology
2024 - Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor Therapy
Journal of Clinical Oncology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Landen, MD
University of Virginia
Stephen Caldwell
University of Virginia
James Platts-Mills, MD
University of Virginia
Eric Houpt
University of Virginia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”